Cyanocobalamin intranasal - Fleming Pharmaceuticals

Drug Profile

Cyanocobalamin intranasal - Fleming Pharmaceuticals

Alternative Names: CaloMist

Latest Information Update: 16 Jan 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Fleming Pharmaceuticals
  • Class Corrinoids; Vitamin B12 analogues
  • Mechanism of Action Vitamin B12 receptor protein agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Vitamin deficiency

Most Recent Events

  • 01 Dec 2007 Launched for Vitamin deficiency in USA (Intranasal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top